4.2 Review

Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research

期刊

BIOMED RESEARCH INTERNATIONAL
卷 2013, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2013/282913

关键词

-

资金

  1. Ministerio de Ciencia e Innovacion [SAF2007-66115]
  2. University of the Basque Country (UPV/EHU) [UFI 11/32]
  3. FEDER
  4. Basque Government

向作者/读者索取更多资源

There is no malaria vaccine currently available, and the most advanced candidate has recently reported a modest 30% efficacy against clinical malaria. Although many efforts have been dedicated to achieve this goal, the research was mainly directed to identify antigenic targets. Nevertheless, the latest progresses on understanding how immune system works and the data recovered from vaccination studies have conferred to the vaccine formulation its deserved relevance. Additionally to the antigen nature, the manner in which it is presented (delivery adjuvants) as well as the immunostimulatory effect of the formulation components (immunostimulants) modulates the immune response elicited. Protective immunity against malaria requires the induction of humoral, antibody-dependent cellular inhibition (ADCI) and effector and memory cell responses. This review summarizes the status of adjuvants that have been or are being employed in the malaria vaccine development, focusing on the pharmaceutical and immunological aspects, as well as on their immunization outcomings at clinical and preclinical stages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据